Memorial Sloan Kettering Cancer Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1884-01-01

Employees: 10K

Market Cap: -

Website: http://www.mskcc.org

Clinical Trials

Escalation of Plerixafor for Mobilization of CD34+ Hematopoietic Progenitor Cells and Evaluation of Globin Gene Transfer in Patients With Sickle Cell Disease

Phase 1

Active, not recruiting

Conditions: Sickle Cell Disease

Interventions: Drug: Plerixafor

First Posted Date: 2014-07-17

Last Posted Date: 2024-11-05

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 25

Registration Number: NCT02193191

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
🇺🇸
Weill Cornell Medical College, New York, New York, United States

Detection of Oncogenic Tumor Mutations in the Urine and Blood of Lung and Colorectal Cancer Patients

Completed

Conditions: Lung Cancer
Colorectal Cancer

First Posted Date: 2014-07-10

Last Posted Date: 2016-09-27

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 84

Registration Number: NCT02186236

Locations: 🇺🇸
Memorial Sloan Kettering West Harrison, West Harrison, New York, United States
🇺🇸
Memoral Sloan Kettering Cancer Center, Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

and more 3 locations

Whole Lung IMRT in Children and Adults With Synovial Sarcoma and Lung Metastases

Phase 2

Completed

Conditions: Synovial Sarcoma
Single or Multiple Lung Metastases

Interventions: Radiation: Whole Lung IMRT

First Posted Date: 2014-07-04

Last Posted Date: 2021-06-29

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 10

Registration Number: NCT02181829

Locations: 🇺🇸
Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Commack, Commack, New York, United States
🇺🇸
Memorial Sloan Kettering Westchester, Harrison, New York, United States

and more 2 locations

Predictive MRI Metrics for Tumor Aggressiveness in Papillary Thyroid Cancer

Completed

Conditions: Papillary Thyroid Cancer

Interventions: Procedure: diffusion weighted (DW) MRI
Procedure: dynamic contrast agent (DCE) MRI

First Posted Date: 2014-06-30

Last Posted Date: 2021-12-08

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 123

Registration Number: NCT02178345

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Carvedilol for the Prevention of Anthracycline/Anti-HER2 Therapy Associated Cardiotoxicity Among Women With HER2-Positive Breast Cancer Using Myocardial Strain Imaging for Early Risk Stratification

Phase 2

Completed

Conditions: Breast Cancer

Interventions: Other: placebo
Drug: Carvedilol

First Posted Date: 2014-06-27

Last Posted Date: 2022-07-12

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 82

Registration Number: NCT02177175

Locations: 🇺🇸
Memorial Sloan Kettering West Harrison, Harrison, New York, United States
🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Clinical Utility of Whole Breast Screening Ultrasound in Patients Undergoing Digital Breast Tomosynthesis

Completed

Conditions: Breast Screening

Interventions: Procedure: breast ultrasound
Procedure: DBT (Full field digital mammography + tomosynthesis)

First Posted Date: 2014-06-25

Last Posted Date: 2023-01-23

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 1494

Registration Number: NCT02174406

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Identifying and Measuring Depression in Older Cancer Patients

Active, not recruiting

Conditions: Older Cancer Patients

Interventions: Behavioral: Patient Interviews
Behavioral: newly developed questionnaire
Behavioral: Pilot Testing the Draft Measure

First Posted Date: 2014-06-25

Last Posted Date: 2024-04-05

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 329

Registration Number: NCT02174055

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Open-Label Study Evaluating the Safety and Tolerability of LJM716, BYL719 and Trastuzumab in Patients With Metastatic HER2+ Breast Cancer

Phase 1

Completed

Conditions: Breast Cancer

Interventions: Drug: BYL719
Drug: LJM716
Drug: TRASTUZUMAB

First Posted Date: 2014-06-19

Last Posted Date: 2021-07-09

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 23

Registration Number: NCT02167854

Locations: 🇺🇸
Memorial Sloan Kettering at Basking Ridge, Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Commack, Commack, New York, United States

and more 3 locations

A Randomized Trial to Assess Patient Quality of Life and Function After Alternative Surgeries for Pathologic Fractures of the Femur

Not Applicable

Active, not recruiting

Conditions: Proximal Femoral Metastases

Interventions: Procedure: long-stem cemented hemiarthroplasty (LSCH)
Procedure: intramedullary nailing (IMN)
Behavioral: questionnaires

First Posted Date: 2014-06-16

Last Posted Date: 2024-07-03

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 73

Registration Number: NCT02164019

Locations: 🇺🇸
University of Rochester Medical Center, Rochester, New York, United States
🇺🇸
Memorial Sloan Kettering Cancer Center 1275 York Avenue, New York, New York, United States
🇺🇸
SUNY Upstate Medical University, Syracuse, New York, United States

and more 3 locations

Sacral Neuromodulation (SNM) With InterStimTM for Bowel Dysfunction Following Surgery for Rectal Cancers With Sphincter Preservation

Phase 2

Terminated

Conditions: Rectal Cancer
for Bowel Dysfunction Following Surgery for Rectal Cancers

Interventions: Device: Implantation of the InterStimTM
Behavioral: MSK BFI questionnaires
Behavioral: The Low Anterior Resection Score (LARS) questionnaires
Behavioral: The EuroQOL5D questionnaires
Behavioral: The Fecal incontinence Quality of Life Scale (FIQOL) questionnaires

First Posted Date: 2014-06-13

Last Posted Date: 2018-02-05

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 4

Registration Number: NCT02163187

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
🇺🇸
Weill Medical College of Cornell University, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy